Détail - canceropole-wordpress

A confidence-based, artificial intelligence pathology model for diagnosis of intrahepatic cholangiocarcinoma.

Cheng Y, Azouzi N, Laurent-Bellue A, Guo Z, Chung T, Zeng Q, Ghodsifard A, Albrecht T, Roessler S, Boulagnon-Rombi C, Vij M, Rela M, Akpinar R, Augustin J, Bazille C, Xu S, Kong S, Lechapt-Zalcman E, Tournigand C, Kempf E, Brustia R, Pawlotsky JM, Braconi C, Caruso S, Ziol M, Goeppert B, Di Tommaso L, Park YN, Calderaro J

Ann Oncol. 2026 03 4;:

[Histoseminar updates for diagnostic practice and therapeutic targeting of colorectal cancer in 2025].

Brunac AC, Boulagnon-Rombi C, Selves J, Bibeau F

Ann Pathol. 2026 01 14;:

Loss of heterozygosity and absence of MAX immunostaining in a prolactinoma associated with multiple endocrine neoplasia type 5 (MEN5).

Delemer B, Florea SM, Decoudier B, Boulagnon-Rombi C, Karna B, Pellegata NS, Buffet A, Beckers A, Pétrossians P, Daly AF

Pituitary. 2025 11 12;28(6):127

Dysphagia associated with portal hypertension and hepatocellular carcinoma, singular coincidence or hidden pathway?

Goncalves T, Letrillart L, Carlier C, Boulagnon-Rombi C, Gigante E

J Hepatol. 2025 07;83(1):e13-e15

Masquerade Syndrome Revealing a Vitreous Metastasis from Adenosquamous Lung Carcinoma in a Patient Treated with Pembrolizumab.

Olory-Garnotel L, Gabison S, Hamzaoui M, Boulagnon-Rombi C, Arndt C

Ocul Immunol Inflamm. 2025 05 21;:1-5

[Case report of a severe Mooren's ulcer].

Meddahi M, Denoyer A, Pouillard F, Didier K, Boulagnon-Rombi C

Ann Pathol. 2024 10 30;:

PIT-EASY survey: validation of the European Pituitary Pathology Group proposal for reporting pituitary neuroendocrine tumors.

Birtolo MF, Jouinot A, Vasiljevic A, Boulagnon-Rombi C, Asioli S, Bousdira G, Tetka LMM, Perbet R, Maurage CA, Appay R, Figarella-Branger D, Gauchotte G, Sturm N, Baussart B, Roncaroli F, Bertherat J, Brue T, Villa C,

Virchows Arch. 2024 06 22;:

Effectiveness of immune checkpoint inhibitors in the treatment of kidney cancer oral metastasis. A case report.

Bruckmann M, Brenet E, Boulagnon-Rombi C, Louvrier A, Mauprivez C

J Stomatol Oral Maxillofac Surg. 2024 05 6;:101913

[A colorful pericardium].

Pham F, Boulagnon-Rombi C

Ann Pathol. 2024 02 8;:

Deep learning-based phenotyping reclassifies combined hepatocellular-cholangiocarcinoma.

Calderaro J, Ghaffari Laleh N, Zeng Q, Maille P, Favre L, Pujals A, Klein C, Bazille C, Heij LR, Uguen A, Luedde T, Di Tommaso L, Beaufrère A, Chatain A, Gastineau D, Nguyen CT, Nguyen-Canh H, Thi KN, Gnemmi V, Graham RP, Charlotte F, Wendum D, Vij M, Allende DS, Aucejo F, Diaz A, Rivière B, Herrero A, Evert K, Calvisi DF, Augustin J, Leow WQ, Leung HHW, Boleslawski E, Rela M, François A, Cha AW, Forner A, Reig M, Allaire M, Scatton O, Chatelain D, Boulagnon-Rombi C, Sturm N, Menahem B, Frouin E, Tougeron D, Tournigand C, Kempf E, Kim H, Ningarhari M, Michalak-Provost S, Gopal P, Brustia R, Vibert E, Schulze K, Rüther DF, Weidemann SA, Rhaiem R, Pawlotsky JM, Zhang X, Luciani A, Mulé S, Laurent A, Amaddeo G, Regnault H, De Martin E, Sempoux C, Navale P, Westerhoff M, Lo RC, Bednarsch J, Gouw A, Guettier C, Lequoy M, Harada K, Sripongpun P, Wetwittayaklang P, Loménie N, Tantipisit J, Kaewdech A, Shen J, Paradis V, Caruso S, Kather JN

Nat Commun. 2023 12 14;14(1):8290

Artificial intelligence-based pathology as a biomarker of sensitivity to atezolizumab-bevacizumab in patients with hepatocellular carcinoma: a multicentre retrospective study.

Zeng Q, Klein C, Caruso S, Maille P, Allende DS, Mínguez B, Iavarone M, Ningarhari M, Casadei-Gardini A, Pedica F, Rimini M, Perbellini R, Boulagnon-Rombi C, Heurgué A, Maggioni M, Rela M, Vij M, Baulande S, Legoix P, Lameiras S, ,Bruges L, Gnemmi V, Nault JC, Campani C, Rhee H, Park YN, Iñarrairaegui M, Garcia-Porrero G, Argemi J, Sangro B, D'Alessio A, Scheiner B, Pinato DJ, Pinter M, Paradis V, Beaufrère A, Peter S, Rimassa L, Di Tommaso L, Vogel A, Michalak S, Boursier J, Loménie N, Ziol M, Calderaro J

Lancet Oncol. 2023 11 8;:

Longitudinal study of cirrhosis development in STAM™ and CCl mouse models using FTIR spectral imaging.

Guillard J, Untereiner V, Garnotel R, Boulagnon-Rombi C, Gobinet C, Proult I, Sockalingum GD, Thiéfin G

Lab Invest. 2023 08 4;:100231

Deep learning for the prediction of the chemotherapy response of metastatic colorectal cancer: comparing and combining H&E staining histopathology and infrared spectral histopathology.

Brunel B, Prada P, Slimano F, Boulagnon-Rombi C, Bouché O, Piot O

Analyst. 2023 07 19;:

Un numéro spécial sur la pathologie inflammatoire du tube digestif

Boulagnon-Rombi C, Svrcek M

Ann Pathol. 2023 06;43(3):165

String of pearls: A remarkable case of atypical vitritis.

Henry A, Olory-Garnotel L, Bouzidra G, Boulagnon-Rombi C

J Fr Ophtalmol. 2023 04 24;:

[Inflammatory bowel diseases: Scoring and pathological reports optimization].

Boulagnon-Rombi C, Marchal A, Lirsac M, Svrcek M

Ann Pathol. 2023 04 12;:

[Drug induced gastro-intestinal tract lesions: A pathologist point of view].

Boulagnon-Rombi C, Dufour C, Chatelain D

Ann Pathol. 2023 03 1;:

Nestin as a diagnostic and prognostic marker for combined hepatocellular-cholangiocarcinoma.

Calderaro J, Di Tommaso L, Maillé P, Beaufrère A, Nguyen CT, Heij L, Gnemmi V, Graham RP, Charlotte F, Chartier S, Wendum D, Vij M, Allende D, Diaz A, Fuster C, Rivière B, Herrero A, Augustin J, Evert K, Calvisi DF, Leow WQ, Wai Leung HH, Bednarsch J, Boleslawski E, Rela M, Wing-Hung Chan A, Forner A, Reig M, Pujals A, Favre L, Allaire M, Scatton O, Uguen A, Trépo E, Sanchez LO, Chatelain D, Remmelink M, Boulagnon-Rombi C, Bazille C, Sturm N, Menahem B, Frouin E, Tougeron D, Tournigand C, Kempf E, Kim H, Ningarhari M, Michalak-Provost S, Kather JN, Gouw ASH, Gopal P, Brustia R, Vibert E, Schulze K, Rüther DF, Weidemann SA, Rhaiem R, Nault JC, Laurent A, Amaddeo G, Regnault H, de Martin E, Sempoux C, Navale P, Shinde J, Bacchuwar K, Westerhoff M, Cheuk-Lam Lo R, Sebbagh M, Guettier C, Lequoy M, Komuta M, Ziol M, Paradis V, Shen J, Caruso S

J Hepatol. 2022 08 17;:

Early detection of relapse by ctDNA sequencing in a patient with metastatic thymic tumor and MEN1 mosaicism.

Lagarde A, Le Collen L, Boulagnon C, Brixi H, Durlach A, Mougel G, Cuny T, Delemer B, Barlier A, Romanet P

J Clin Endocrinol Metab. 2022 07 29;:

Aseptic splenic abscesses as the inaugural manifestation of Crohn's disease.

Favarel-Garrigues M, Cadiot G, Bermejo M, Boulagnon-Rombi C, Bani-Sadr F, Hentzien M

Clin Res Hepatol Gastroenterol. 2022 07 2;:101989

One-year COVID-19 outcomes on the oncology care patient pathway: Results of a French descriptive, cross-sectional comprehensive study (ONCOCARE-COV).

Laurent L, Brugel M, Carlier C, Clere F, Bertrand A, Botsen D, Boulagnon-Rombi C, Dalstein V, Debreuve-Theresette A, Deguelte S, Garbar C, Mahmoudi R, Marechal A, Morland D, Rey JB, Schvartz C, Vallet C, Merrouche Y, Slimano F, Bouché O

Cancer Med. 2022 05 20;:

Increased intravitreal glucose in rhegmatogenous retinal detachment.

Arndt C, Hubault B, Hayate F, Barbe C, Afriat M, Gillery P, Ramont L, Henry A, Boulagnon-Rombi C

Eye (Lond). 2022 Mar 10;:

Discoidin Domain Receptor 1 Expression in Colon Cancer: Roles and Prognosis Impact.

Ben Arfi K, Schneider C, Bennasroune A, Bouland N, Wolak-Thierry A, Collin G, Le CC, Toussaint K, Hachet C, Lehrter V, Dedieu S, Bouché O, Morjani H, Boulagnon-Rombi C, Appert-Collin A

Cancers (Basel). 2022 Feb 13;14(4):

Beaudoux O, Larre I, Boulagnon-Rombi C

Ann Pathol. 2022 Feb 4;:

Antibacterial and Immunomodulatory Properties of Acellular Wharton's Jelly Matrix.

Dubus M, Scomazzon L, Chevrier J, Ledouble C, Baldit A, Braux J, Gindraux F, Boulagnon C, Audonnet S, Colin M, Rammal H, Mauprivez C, Kerdjoudj H

Biomedicines. 2022 Jan 21;10(2):

Assessment of Ovarian Tumor Growth in Wild-Type and Lumican-Deficient Mice: Insights Using Infrared Spectral Imaging, Histopathology, and Immunohistochemistry.

Nizet P, Untereiner V, Sockalingum GD, Proult I, Terryn C, Jeanne A, Nannan L, Boulagnon-Rombi C, Sellier C, Rivet R, Ramont L, Brézillon S

Cancers (Basel). 2021 Nov 26;13(23):

Immune profiling of combined hepatocellular-cholangiocarcinoma reveals distinct subtypes and activation of gene signatures predictive of response to immunotherapy.

Nguyen CT, Caruso S, Maillé P, Beaufrère A, Augustin J, Favre L, Pujals A, Boulagnon-Rombi C, Rhaiem R, Amaddeo G, Di Tommaso L, Luciani A, Regnault H, Brustia R, Scatton O, Charlotte F, Brocheriou I, Sommacale D, Soussan P, Leroy V, Laurent A, Le VK, Ta VT, Trinh HS, Tran TL, Gentien D, Rapinat A, Nault JC, Allaire M, Mulé S, Zucman-Rossi J, Pawlotsky JM, Tournigand C, Lafdil F, Paradis V, Calderaro J

Clin Cancer Res. 2021 Nov 16;:

Apelin expression deficiency in mice contributes to vascular stiffening by extracellular matrix remodeling of the aortic wall.

Romier B, Dray C, Vanalderwiert L, Wahart A, Hocine T, Dortignac A, Garbar C, Garbar C, Boulagnon C, Bouland N, Maurice P, Bennasroune A, Sartelet H, Martiny L, Duca L, Valet P, Blaise S

Sci Rep. 2021 Nov 15;11(1):22278

Hepatotoxicity of metronidazole in Cockayne syndrome: A clinical report.

Hunaut T, Boulagnon-Rombi C, Thorn H, Doco-Fenzy M, Thiéfin G

Eur J Med Genet. 2021 Nov 9;:104388

LRP-1 Matricellular Receptor Involvement in Triple Negative Breast Cancer Tumor Angiogenesis.

Campion O, Thevenard Devy J, Billottet C, Schneider C, Etique N, Dupuy JW, Raymond AA, Boulagnon Rombi C, Meunier M, Djermoune EH, Lelièvre E, Wahart A, Bour C, Hachet C, Cairo S, Bikfalvi A, Dedieu S, Devy J

Biomedicines. 2021 Oct 9;9(10):

Targeting Ovarian Carcinoma with TSP-1:CD47 Antagonist TAX2 Activates Anti-Tumor Immunity.

Jeanne A, Sarazin T, Charlé M, Moali C, Fichel C, Boulagnon-Rombi C, Callewaert M, Andry MC, Diesis E, Delolme F, Rioult D, Dedieu S

Cancers (Basel). 2021 Oct 7;13(19):

Utility of genetic sequencing in the diagnosis of a very large orbital tumor.

Santorini M, Durbant E, Boulagnon C, Ducasse A, Arndt C, Denoyer A, Larré I

J Fr Ophtalmol. 2021 Sep 8;:

A large extended family with hyperparathyroidism-jaw tumor syndrome due to deletion of the third exon of CDC73: clinical and molecular features.

Le Collen L, Barraud S, Braconnier A, Coppin L, Zachar D, Boulagnon C, Deguelte S, Souchon PF, Spodenkiewicz M, Poirsier C, Aubert S, Odou MF, Delemer B

Endocrine. 2021 May 17;:

Influence of postoperative radiotherapy target volumes in unilateral head and neck carcinoma of unknown primary: A multicentric study using propensity score.

Brenet E, Philouze P, Schiffler C, Pommier P, Crozes C, Benzerdjeb N, Monchet E, Boulagnon-Rombi C, Ton Van J, Podeur F, Servagi-Vernat S, Liem X, Merol JC, Ceruse P, Serre AA, Chabaud S, Julieron M, Deneuve S

Radiother Oncol. 2021 Apr 27;160:1-8

Adverse effects of oseltamivir phosphate therapy on the liver of LDLR-/- mice without any benefit on atherosclerosis and thrombosis.

Bocquet O, Wahart A, Sarazin T, Vincent E, Schneider C, Fougerat A, Gayral S, Henry A, Blaise S, Romier-Crouzet B, Boulagnon C, Jaisson S, Gillery PP, Bennasroune A, Sartelet H, Laffargue M, Martiny PL, Duca PL, Maurice P

J Cardiovasc Pharmacol. 2021 Feb 25;:

Automatic Identification of Paraffin Pixels on FTIR Images Acquired on FFPE Human Samples.

Boutegrabet W, Guenot D, Bouché O, Boulagnon-Rombi C, Marchal Bressenot A, Piot O, Gobinet C

Anal Chem. 2021 Feb 16;:

Anti-Tumoral and Anti-Angiogenic Effects of Low-Diluted on Melanoma.

Fuselier C, Quemener S, Dufay E, Bour C, Boulagnon-Rombi C, Bouland N, Djermoune EH, Devy J, Martiny L, Schneider C

Front Oncol. 2021 ;11:597503

PD-L1 Expression in 65 Conjunctival Melanomas and Its Association with Clinical Outcome.

Lassalle S, Nahon-Esteve S, Frouin E, Boulagnon-Rombi C, Josselin N, Cassoux N, Barnhill R, Scheller B, Baillif S, Hofman P

Int J Mol Sci. 2020 Nov 30;21(23):

AgeR deletion decreases soluble fms-like tyrosine kinase 1 production and improves post-ischemic angiogenesis in uremic mice.

Dupont V, Al-Rifai R, Poitevin G, Ortillon J, Jayyosi L, Terryn C, Francois C, Rieu P, Fritz G, Boulagnon-Rombi C, Fichel C, Schmidt AM, Tournois C, Nguyen P, Touré F

Angiogenesis. 2020 Sep 23;:

[Massively invasive orbital melanoma: Uveal or conjunctival origin?]

Beaudoux O, Larre I, Litre F, Boulagnon-Rombi C

Ann Pathol. 2020 Jul 23;:

Expression of the Serrated Markers Annexin A10 or Gremlin1 in Colonic Adenocarcinomas: Morphology and Prognostic Values.

Marquet B, Marchal Bressenot A, Fichel C, Bouland N, Barbe C, Bouché O, Kianmanesh R, Diebold MD, Boulagnon-Rombi C

Pathol. Oncol. Res.. 2020 Jun 24;:

COVID-19 epidemic: Proposed alternatives in the management of digestive cancers: A French intergroup clinical point of view (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, SFR).

Di Fiore F, Bouché O, Lepage C, Sefrioui D, Gangloff A, Schwarz L, Tuech JJ, Aparicio T, Lecomte T, Boulagnon-Rombi C, Lièvre A, Manfredi S, Phelip JM, Michel P, ,,,,,,,,

Dig Liver Dis. 2020 May 14;:

Functional Interplay Between Collagen Network and Cell Behavior Within Tumor Microenvironment in Colorectal Cancer.

Le CC, Bennasroune A, Langlois B, Salesse S, Boulagnon-Rombi C, Morjani H, Dedieu S, Appert-Collin A

Front Oncol. 2020 ;10:527

Label-Free Infrared Spectral Histology of Skin Tissue Part I: Impact of Lumican on Extracellular Matrix Integrity.

Nannan L, Untereiner V, Proult I, Boulagnon-Rombi C, Colin-Pierre C, Sockalingum GD, Brézillon S

Front Cell Dev Biol. 2020 ;8:320

Label-Free Infrared Spectral Histology of Skin Tissue Part II: Impact of a Lumican-Derived Peptide on Melanoma Growth.

Brézillon S, Untereiner V, Mohamed HT, Ahallal E, Proult I, Nizet P, Boulagnon-Rombi C, Sockalingum GD

Front Cell Dev Biol. 2020 ;8:377

Is the Mirror Image Method Really Useful in Tumor Tissue Bank Quality Control?

Dudez O, Dalstein V, Kanagaratnam L, Nasri S, Coquelet C, Fichel C, Bouland N, Lemaire E, Diebold MD, Marchal-Bressenot A, Boulagnon-Rombi C

Biopreserv Biobank. 2019 Jun 24;:

[Carcinoma cuniculatum: An unusual oral tumor].

Ben Arfi K, Marchal A, Hafian H, Boulagnon-Rombi C

Ann Pathol. 2019 May 19;:

Receptor for advanced glycation end products: a key molecule in the genesis of chronic kidney disease vascular calcification and a potential modulator of sodium phosphate co-transporter PIT-1 expression.

Belmokhtar K, Ortillon J, Jaisson S, Massy ZA, Boulagnon Rombi C, Doué M, Maurice P, Fritz G, Gillery P, Schmidt AM, Rieu P, Touré F

Nephrol. Dial. Transplant.. 2019 Feb 18;:

[Pathologist versus social media: A survival guide].

Liddell C, Morini A, Mittler F, Boulagnon-Rombi C

Ann Pathol. 2019 Jan 31;:

An atypical pituitary incidentaloma.

Ly S, Boulagnon-Rombi C

Neurochirurgie. 2018 Nov 1;:

CD160 Expression in Retinal Vessels Is Associated With Retinal Neovascular Diseases.

Henry A, Boulagnon-Rombi C, Menguy T, Giustiniani J, Garbar C, Mascaux C, Labrousse M, Milas C, Barbe C, Bensussan A, Durlach V, Arndt C

Invest. Ophthalmol. Vis. Sci.. 2018 Jun 1;59(7):2679-2686

LRP1 expression in colon cancer predicts clinical outcome.

Boulagnon-Rombi C, Schneider C, Leandri C, Jeanne A, Grybek V, Bressenot AM, Barbe C, Marquet B, Nasri S, Coquelet C, Fichel C, Bouland N, Bonnomet A, Kianmanesh R, Lebre AS, Bouché O, Diebold MD, Bellon G, Dedieu S

Oncotarget. 2018 Feb 6;9(10):8849-8869

Collagen-Based Medical Device as a Stem Cell Carrier for Regenerative Medicine.

Aubert L, Dubus M, Rammal H, Bour C, Mongaret C, Boulagnon-Rombi C, Garnotel R, Schneider C, Rahouadj R, Laurent C, Gangloff SC, Velard F, Mauprivez C, Kerdjoudj H

Int J Mol Sci. 2017 Oct 21;18(10):

Lumican delays melanoma growth in mice and drives tumor molecular assembly as well as response to matrix-targeted TAX2 therapeutic peptide.

Jeanne A, Untereiner V, Perreau C, Proult I, Gobinet C, Boulagnon-Rombi C, Terryn C, Martiny L, Brézillon S, Dedieu S

Sci Rep. 2017 Aug;7(1):7700

Prospective validation of a lymphocyte infiltration prognostic test in stage III colon cancer patients treated with adjuvant FOLFOX.

Emile JF, Julié C, Le Malicot K, Lepage C, Tabernero J, Mini E, Folprecht G, Van Laethem JL, Dimet S, Boulagnon-Rombi C, Allard MA, Penault-Llorca F, Bennouna J, Laurent-Puig P, Taieb J, ,,,,,,,,,,,,,,,,

Eur. J. Cancer. 2017 Jun;82:16-24

[Systemic lupus erythematosus presenting as severe alveolar hypoventilation and the shrinking lung syndrome].

Ammar Y, Launois C, Perotin JM, Dury S, Servettaz A, Perdu D, Vallerand H, Nardi J, Boulagnon-Rombi C, Pluot M, Lebargy F, Deslee G

Rev Mal Respir. 2017 May;34(5):571-575

Immunohistochemical Approach to the Differential Diagnosis of Meningiomas and Their Mimics.

Boulagnon-Rombi C, Fleury C, Fichel C, Lefour S, Marchal Bressenot A, Gauchotte G

J. Neuropathol. Exp. Neurol.. 2017 04 1;76(4):289-298

Harnessing Wharton's jelly stem cell differentiation into bone-like nodule on calcium phosphate substrate without osteoinductive factors.

Mechiche Alami S, Rammal H, Boulagnon-Rombi C, Velard F, Lazar F, Drevet R, Laurent Maquin D, Gangloff SC, Hemmerlé J, Voegel JC, Francius G, Schaaf P, Boulmedais F, Kerdjoudj H

Acta Biomater. 2017 Feb;49:575-589

Enterovirus but not Parvovirus B19 is associated with idiopathic dilated cardiomyopathy and endomyocardial CD3, CD68, or HLA-DR expression.

N'Guyen Y, Lesaffre F, Metz D, Tassan S, Saade Y, Boulagnon C, Fornes P, Renois F, Andreoletti L

J. Med. Virol.. 2017 01;89(1):55-63

Cavernous sinus thrombosis secondary to aspergillus granuloma: A case report and review of the literature.

Brenet E, Boulagnon-Rombi C, N'guyen Y, Litré CF

Auris Nasus Larynx. 2016 Oct;43(5):566-9

Matricellular TSP-1 as a target of interest for impeding melanoma spreading: towards a therapeutic use for TAX2 peptide.

Jeanne A, Boulagnon-Rombi C, Devy J, Théret L, Fichel C, Bouland N, Diebold MD, Martiny L, Schneider C, Dedieu S

Clin. Exp. Metastasis. 2016 Oct;33(7):637-49

Signaling of Serum Amyloid A Through Receptor for Advanced Glycation End Products as a Possible Mechanism for Uremia-Related Atherosclerosis.

Belmokhtar K, Robert T, Ortillon J, Braconnier A, Vuiblet V, Boulagnon-Rombi C, Diebold MD, Pietrement C, Schmidt AM, Rieu P, Touré F

Arterioscler. Thromb. Vasc. Biol.. 2016 May;36(5):800-9

Severe apoptotic enteropathy caused by methotrexate treatment for rheumatoid arthritis.

Toquet S, Nguyen Y, Sabbagh A, Djerada Z, Boulagnon C, Bani-Sadr F

Joint Bone Spine. 2016 Mar;83(2):217-9

Biobanking of Fresh-Frozen Human Adenocarcinomatous and Normal Colon Tissues: Which Parameters Influence RNA Quality?

Galissier T, Schneider C, Nasri S, Kanagaratnam L, Fichel C, Coquelet C, Diebold MD, Kianmanesh R, Bellon G, Dedieu S, Marchal Bressenot A, Boulagnon-Rombi C

PLoS ONE. 2016 ;11(4):e0154326

Cytopathology of Vitreous Humor Samples in Routine Practice.

Boulagnon C, Ducasse A, Patey M, Diebold MD, Arndt C

Acta Cytol.. 2016 ;60(1):65-73

[Giant cell arteritis and unexplained hypoxemia].

Faroux L, Tassan-Mangina S, Aludaat C, Boulagnon C, Bauley K, Nazeyrollas P, Metz D

Presse Med. 2015 Dec;44(12 Pt 1):1276-8

Development and validation of the Nancy histological index for UC.

Marchal-Bressenot A, Salleron J, Boulagnon-Rombi C, Bastien C, Cahn V, Cadiot G, Diebold MD, Danese S, Reinisch W, Schreiber S, Travis S, Peyrin-Biroulet L

Gut. 2015 Oct 13. pii: gutjnl-2015-310187